Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid

被引:59
作者
Bals, R
Weiner, DJ
Meegalla, RL
Accurso, F
Wilson, JM
机构
[1] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Inst Human Gene Therapy, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Mol & Cellular Engn, Inst Human Gene Therapy, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA USA
[5] Univ Colorado, Sch Med, Denver, CO USA
[6] Childrens Hosp, Denver, CO 80218 USA
关键词
D O I
10.1165/ajrcmb.25.1.4436
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The link between the genetic defect in cystic fibrosis (CF) and the recently described breach in pulmonary host defense has focused on the role of salt and water metabolism in the airways. Using a human bronchial xenograft model we demonstrate a salt-independent abnormality in bacterial killing in CF airway surface fluid (ASF). Biochemical characterization implicates the absence or dysfunction of a molecule critical to the constitution of normal bacterial killing. Our study suggests that CF transmembrane conductance regulator (CFTR) deficiency causes a primary abnormality in the composition of ASF that leads to a salt-independent defect in host defense. Importantly, this defect is corrected by adenovirus-mediated gene transfer of CFTR.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 17 条
[1]   The innate immune system in cystic fibrosis lung disease [J].
Bals, R ;
Weiner, DJ ;
Wilson, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) :303-307
[2]   The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface [J].
Bals, R ;
Wang, XR ;
Zasloff, M ;
Wilson, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9541-9546
[3]   Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung [J].
Bals, R ;
Wang, XR ;
Wu, ZR ;
Freeman, T ;
Bafna, V ;
Zasloff, M ;
Wilson, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05) :874-880
[4]  
Bradbury Neil A., 1999, Physiological Reviews, V79, pS175
[5]   EXPRESSION OF THE CYSTIC-FIBROSIS GENE IN ADULT HUMAN LUNG [J].
ENGELHARDT, JF ;
ZEPEDA, M ;
COHN, JA ;
YANKASKAS, JR ;
WILSON, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :737-749
[6]   INVIVO RETROVIRAL GENE-TRANSFER INTO HUMAN BRONCHIAL EPITHELIA OF XENOGRAFTS [J].
ENGELHARDT, JF ;
YANKASKAS, JR ;
WILSON, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (06) :2598-2607
[7]   DIRECT GENE-TRANSFER OF HUMAN CFTR INTO HUMAN BRONCHIAL EPITHELIA OF XENOGRAFTS WITH E1-DELETED ADENOVIRUSES [J].
ENGELHARDT, JF ;
YANG, YP ;
STRATFORDPERRICAUDET, LD ;
ALLEN, ED ;
KOZARSKY, K ;
PERRICAUDET, M ;
YANKASKAS, JR ;
WILSON, JM .
NATURE GENETICS, 1993, 4 (01) :27-34
[8]   Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis [J].
Goldman, MJ ;
Anderson, GM ;
Stolzenberg, ED ;
Kari, UP ;
Zasloff, M ;
Wilson, JM .
CELL, 1997, 88 (04) :553-560
[9]   Cystic fibrosis and the salt controversy [J].
Guggino, WB .
CELL, 1999, 96 (05) :607-610
[10]  
KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075